Mycomune R

This page contains information on Mycomune R for veterinary use.
The information provided typically includes the following:
  • Mycomune R Indications
  • Warnings and cautions for Mycomune R
  • Direction and dosage information for Mycomune R

Mycomune R

This treatment applies to the following species:
Manufacturer: Ceva Biomune

MYCOPLASMA BOVIS BACTERIN

Mycomune R Indications

This bacterin is recommended as an aid in the prevention of respiratory disease in calves caused by Mycoplasma bovis.

Dosage And Directions

It is recommended to vaccinate only healthy calves.

Shake well before use. Using aseptic technique, a 2 ml dose is subcutaneously administered in the neck to calves 3 weeks of age or older. It is recommended that animals are vaccinated 3 times at 2 to 4 week intervals. Semi-annual revaccination is recommended.

In case of anaphylactic reaction, administer epinephrine.

Mycomune R Caution

Do not vaccinate within 21 days of slaughter.

Use entire contents when first opened. Store at 35-45°F (2-7°C).

This product contains an adjuvant, and accidental injection into a human may cause a serious localized reaction. Seek medical attention immediately.

Notice

This bacterin has undergone rigid potency, safety and purity tests and meets Biomune and USDA requirements. This product is nonreturnable.

Patent pending

FOR VETERINARY USE ONLY

BIOMUNE CO., Lenexa, KS 66215 USA

Phone (913) 894-0230

U.S. Vet Lic. No. 368

Presentation: 10 doses (20 mL) and 10 x 10 doses.

NAC No.: 11290631

CEVA BIOMUNE
8906 ROSEHILL ROAD, LENEXA, KS, 66215
Telephone:   913-894-0230
Fax:   913-894-0236
Website:   www.ceva-us.com
Every effort has been made to ensure the accuracy of the Mycomune R information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web2)